Trial Profile
A study investigating the effect of epoprostenol in patients with idiopathic, heritable or anorexigen use associated pulmonary arterial hypertension registered in French pulmonary hypertension registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 Dec 2015
Price :
$35
*
At a glance
- Drugs Epoprostenol (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- 08 Dec 2015 New trial record